OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI): 4 Brokerage firm Analysts have agreed with the mean estimate for the short term price target of $7.38 in OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI). However, the stock price could fluctuate by $ 4.61 from the estimate as it is suggested by the standard deviation reading. The higher estimate has been put at $14 price target with the lower price estimate is calculated at $4
The short interest information of the company was disclosed in the recent information. OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI), In a major positive the short interest in OncoGenex Pharmaceuticals Inc. – Common Shares plummeted by 20.7% or 89,935 shares. The final shorts are 1.7% of the total floated shares. The positions dropped from 434,273 shares on January 30,2015 to 344,338 on February 13,2015. Inculcating the per-day average trading of 180,040 shares, the days to cover are 2.
Shares of OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI) rose by 1.1% in the past week and 14.18% for the last 4 weeks. In the past week, the counter has outperformed the S&P 500 by 1.38% and the outperformance increases to 8.24% for the last 4 weeks.
OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI) made into the market gainers list with the shares advancing 7.88% or 0.19 points. Due to strong positive momentum, the stock ended at $2.6, which is also near the days high of $2.72. The stock began the session at $2.42 and the volume stood at 1,392,016 shares. The previous session had ended at $2.41. The 52-week high of the shares is $14.25 and the yearly low is $1.92. The company is a major component of the market with a cap of $55 million and is a highly liquid scrip with 21,281,000 shares in outstanding.
